Evidence map›Paper›PMID 33130150›Full record

ArticleJournal of molecular and cellular cardiology2021

Interleukin-1α dependent survival of cardiac fibroblasts is associated with StAR/STARD1 expression and improved cardiac remodeling and function after myocardial infarction.

Talya Razin, Naomi Melamed-Book, Jasmin Argaman, Iris Galin, Yosef Lowy, Eli Anuka, Nili Naftali-Shani, Michal Kandel-Kfir, Benjamin P Garfinkel, Shlomi Brielle and 7 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Talya RazinDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: talya.razin@mail.huji.ac.il.
Naomi Melamed-BookBio-Imaging Unit, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: book@mail.huji.ac.il.
Jasmin ArgamanDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.
Iris GalinDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: Iris.Galin@mail.huji.ac.il.
Yosef LowyDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: yosef.levi1@mail.huji.ac.il.
Eli AnukaDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: eli.anuka@mail.huji.ac.il.
Nili Naftali-ShaniNeufeld Cardiac Research Institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Tamman Cardiovascular Research Institute, and Sheba Center of Regenerative Medicine, Stem Cells and Tissue Engineering, Sheba Medical Center, Tel-Hashomer, Israel. Electronic address: Nili.Naftali-shani@sheba.health.gov.il.
Michal Kandel-KfirBert W. Strassburger Lipid Center, Sheba Medical Center, Tel Hashomer, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: Michal.KandelKfir-@sheba.health.gov.il.
Benjamin P GarfinkelDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: bgarfinkel@hsph.harvard.edu.
Shlomi BrielleDepartment of Cell and Developmental Biology, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: shlomi.brielle@mail.huji.ac.il.
Zvi GranotDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Hebrew University Medical School, 91120 Jerusalem, Israel. Electronic address: zvikag@ekmd.huji.ac.il.
Ron N ApteShraga Segal Department of Microbiology and Immunology, Ben-Gurion University, Beer-Sheva, Israel. Electronic address: rapte@bgu.ac.il.
Simon J ConwayHerman B. Wells Center for Pediatric Research, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, IN 46202, United States. Electronic address: siconway@iu.edu.
Jeffery D MolkentinDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, OH, United States. Electronic address: Jeff.Molkentin@cchmc.org.
Yehuda KamariBert W. Strassburger Lipid Center, Sheba Medical Center, Tel Hashomer, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Israel. Electronic address: yehuda.kamari@sheba.health.gov.il.
Jonathan LeorNeufeld Cardiac Research Institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Tamman Cardiovascular Research Institute, and Sheba Center of Regenerative Medicine, Stem Cells and Tissue Engineering, Sheba Medical Center, Tel-Hashomer, Israel. Electronic address: jonathan.leor@sheba.health.gov.il.
Joseph OrlyDepartment of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel. Electronic address: orly@vms.huji.ac.il.
Hebrew University of Jerusalem · ILTel Aviv University · ILBen-Gurion University of the Negev · ILIndiana University – Purdue University Indianapolis · USSheba Medical Center · ILUniversity of Cincinnati · US

Funding

Mechanisms of cardiac and pulmonary fibrosis in relation to TGF-beta signaling and miR-145 functionR01HL135657 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI CONWAY, SIMON JAMES, LILLY, BRENDA J · 2017 to 2020
$1.7M
Cardioprotection and uncoupling myofibroblast-myocyte communicationsR01HL148165 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CONWAY, SIMON JAMES, RUBART-VAN DER LOHE, MICHAEL · 2019 to 2022
$1.6M
NHLBI NIH HHS R01 HL135657NHLBI NIH HHS R01 HL148165
6 · The paper itself

Abstract

aimsOne unaddressed aspect of healing after myocardial infarction (MI) is how non-myocyte cells that survived the ischemic injury, keep withstanding additional cellular damage by stress forms typically arising during the post-infarction inflammation. Here we aimed to determine if cell survival is conferred by expression of a mitochondrial protein novel to the cardiac proteome, known as steroidogenic acute regulatory protein, (StAR/STARD1). Further studies aimed to unravel the regulation and role of the non-steroidogenic cardiac StAR after MI. METHODS AND

resultsFollowing permanent ligation of the left anterior descending coronary artery in mouse heart, timeline western blot analyses showed that StAR expression corresponds to the inflammatory response to MI. Following the identification of StAR in mitochondria of cardiac fibroblasts in culture, confocal microscopy immunohistochemistry (IHC) identified StAR expression in left ventricular (LV) activated interstitial fibroblasts, adventitial fibroblasts and endothelial cells. Further work with the primary fibroblasts model revealed that interleukin-1α (IL-1α) signaling via NF-κB and p38 MAPK pathways efficiently upregulates the expression of the Star gene products. At the functional level, IL-1α primed fibroblasts were protected against apoptosis when exposed to cisplatin mimicry of in vivo apoptotic stress; yet, the protective impact of IL-1α was lost upon siRNA mediated StAR downregulation. At the physiological level, StAR expression was nullified during post-MI inflammation in a mouse model with global IL-1α deficiency, concomitantly resulting in a 4-fold elevation of apoptotic fibroblasts. Serial echocardiography and IHC studies of mice examined 24 days after MI revealed aggravation of LV dysfunction, LV dilatation, anterior wall thinning and adverse tissue remodeling when compared with loxP control hearts.

conclusionsThis study calls attention to overlooked aspects of cellular responses evolved under the stress conditions associated with the default inflammatory response to MI. Our observations suggest that LV IL-1α is cardioprotective, and at least one mechanism of this action is mediated by induction of StAR expression in border zone fibroblasts, which renders them apoptosis resistant. This acquired survival feature also has long-term ramifications on the heart recovery by diminishing adverse remodeling and improving the heart function after MI.

Indexed as

Gene Expression RegulationAnimalsApoptosisBiomarkersCells, CulturedCytokinesDisease Models, AnimalDisease SusceptibilityFemaleFibroblastsFluorescent Antibody TechniqueInterleukin-1alphaMaleMiceMice, KnockoutMyocardial InfarctionBiomarkersCytokinesIl1a protein, mouseInterleukin-1alphaPhosphoproteinsSteroidogenic Acute Regulatory ProteinApoptosisCardiac fibroblastsCardiac remodelingIL-1αMyocardial infarctionStAR

Identifiers

PMID33130150
PMCPMC11492233
OpenAlexW3096952380

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.